Bora Pharmaceuticals Co., LTD.

Informe acción TWSE:6472

Capitalización de mercado: NT$78.5b

Salud financiera de hoja de balance de Bora Pharmaceuticals

Salud financiera controles de criterios 5/6

Bora Pharmaceuticals tiene un patrimonio de accionistas total de NT$11.8B y una deuda total de NT$4.1B, lo que sitúa su ratio deuda-patrimonio en 35%. Sus activos y pasivos totales son NT$25.1B y NT$13.3B respectivamente. El BAIT de Bora Pharmaceuticals es de NT$5.2B, por lo que su ratio de cobertura de intereses es de 48.5. Tiene efectivo e inversiones a corto plazo que ascienden a NT$3.4B.

Información clave

71.5%

Ratio deuda-patrimonio

NT$8.20b

Deuda

Ratio de cobertura de intereses46.6x
EfectivoNT$8.39b
PatrimonioNT$11.46b
Total pasivoNT$19.20b
Activos totalesNT$30.66b

Actualizaciones recientes sobre salud financiera

Recent updates

Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Jun 13
Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?

Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Apr 10
Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Apr 08
Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt

Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Mar 14
Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality

Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Apr 30
Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Mar 17
Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?

Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

Feb 17
Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment

New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Jan 27
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)

Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

Jan 19
Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt

We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Dec 29
We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings

Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Dec 09
Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$10.6B) de 6472 superan a sus pasivos a corto plazo (NT$8.2B).

Pasivo a largo plazo: Los activos a corto plazo de 6472 (NT$10.6B) superan a sus pasivos a largo plazo (NT$5.1B).


Historial y análisis de deuda-patrimonio

Nivel de deuda: 6472 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 6472 ha crecido de 38.2% a 71.5% en los últimos 5 años.

Cobertura de la deuda: La deuda de 6472 está bien cubierta por el flujo de caja operativo (111.9%).

Cobertura de intereses: Los pagos de intereses de la deuda de 6472 están bien cubiertos por el BAIT (48.5x cobertura).


Hoja de balance


Descubre empresas con salud financiera